Insmed (INSM)
(Delayed Data from NSDQ)
$111.61 USD
+0.37 (0.33%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $111.60 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INSM 111.61 +0.37(0.33%)
Will INSM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INSM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSM
Insmed (INSM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know
INSM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should iShares Russell 2000 ETF (IWM) Be on Your Investing Radar?
Insmed Stock Jumps 29% on Encouraging PAH Study Results
Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar?
Other News for INSM
October 17th Options Now Available For Insmed (INSM)
Insmed Inc (INSM) Announces Positive Phase 2b Study Results for Pulmonary Arterial Hypertension ...
ClearBridge Small Cap Growth Portfolios Q2 2025 Commentary
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
ClearBridge Small Cap Growth Fund Q2 2025 Commentary